Leading the Quest to Treat Gynecological Cancers
The Division of Gynecologic Oncology at Cedars-Sinai provides treatment for cancers that affect a woman's reproductive system. These include cancers of the vulva, vagina, cervix, uterus, fallopian tubes or ovaries.
Under the director of Beth Y. Karlan, MD, Director of Gynecologic Oncology, the Division brings together an expert team of gynecologists, oncologists, pathologists and medical researchers to provide state-of-the art diagnosis and treatment of women's cancers.
Cancers of women's reproductive systems and breast cancer are being studied at the Women's Cancer Research Institute to seek the cause of women's cancers, ways of detecting them earlier and more effective treatments.
The Division of Gynecologic Oncology of the Department of Obstetrics and Gynecology at Cedars-Sinai provides women with treatment from board-certified gynecologic oncologists. Outpatient Cancer Center.
The care provided at Cedars-Sinai to women with gynecological cancers is continually monitored and reported. To learn more about the care provided at Cedars-Sinai for these conditions, click here.
The Division's specialists work in close partnership with medical and radiation oncologists, as well as other sub-specialists, when conditions and complications call for more information and experience. Pain management, psychosocial, nutritional and home care teams actively participate in appropriate aspects of each woman's care.
Cedars-Sinai's Gynecologic Oncology staff continually participates in clinical trials sponsored by the National Cancer Institute's Gynecologic Oncology Group and the nation's leading pharmaceutical companies. Clinical trials offer new drugs and treatments that can be made available for eligible patients.
Almost all chemotherapies, transfusions and other treatment procedures can be provided on an outpatient basis at the
Gilda Radner Cancer Detection Program
The Gilda Radner Cancer Detection Program is a nonprofit organization dedicated to facilitating ovarian cancer research, specifically aimed at ovarian cancer screening in high risk women with the BRCA1 or BRCA2 gene mutation. Founded in 1991, the program has collected data for more than 1,200 participants.
Women's Cancer Research Institute
The Women's Cancer Research Institute at Cedars-Sinai Medical Center is a multidisciplinary program working to reduce the threat of cancer to women through research, education, early detection and prevention. Established in 2002, the Institute works side by side with Cedars-Sinai's patient care programs and services to integrate innovative research across a wide spectrum of programs devoted to preventing, diagnosing and treating women's cancers.
